创伤后输血量与生存结局的关联:基于日本全国创伤登记数据库的分析揭示输血限量
该研究利用日本创伤数据库(2019-2021年)纳入18岁以上、伤后24小时内接受平衡输血的5123例患者,来自165家医院,分析红细胞输注总量与出院生存的关联。与输注4-9 U者相比,输注10-19、20-29和≥30 U者的院内生存比值比分别为0.62(95%CI 0.55-0.75)、0.32(95%CI 0.25-0.40)和0.15(95%CI 0.12-0.20)。生存概率随输血量增加持续下降但无可识别阈值,接受50 U和80 U红细胞者生存率仍分别>40%和>20%。作者认为无阈值且生存概率并非极低支持在临床判断持续输血有益时进行大量输血,需结合具体临床情境决策。
要点
- 与输注4-9 U红细胞者相比,输注10-19、20-29和≥30 U者的出院生存比值比分别为0.62(95%CI 0.55-0.75)、0.32(95%CI 0.25-0.40)和0.15(95%CI 0.12-0.20)。
- 生存概率随红细胞输注量增加持续下降,但未发现可识别的阈值。
- 接受50 U和80 U红细胞的患者生存率仍分别>40%和>20%。
- 作者认为,无阈值且生存概率并非极低,支持在临床医生认为持续输血有益时进行大量输血。
- 输血量与出院生存的关联在各亚组间存在显著交互作用。
适用人群与场景
- 日本创伤数据库(2019-2021年)中18岁及以上、伤后24小时内接受平衡输血的患者。
研究设计与关键结果
- 研究类型为基于日本创伤数据库(2019-2021年)的分析,纳入5123例来自165家医院的患者。
- 与输注4-9 U红细胞者相比,输注10-19 U、20-29 U和≥30 U者的院内出院生存比值比分别为0.62(95%CI 0.55-0.75)、0.32(95%CI 0.25-0.40)和0.15(95%CI 0.12-0.20)。
- 生存概率随输血量增加持续下降,无可识别阈值;接受50 U和80 U红细胞者生存率仍分别>40%和>20%。
- 输血量与出院生存的关联在各亚组间存在显著交互作用。
证据类型、等级与局限
- 证据类型:基于日本全国创伤登记数据库的治疗/管理类研究,证据等级Level III。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,生存概率随输血量增加持续下降但无阈值且生存概率并非极低,支持在临床医生认为持续输血有益时进行大量输血。
- 作者指出,决策时必须考虑每个临床情境的独特背景。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Whether and how the transfusion volume should be limited in resuscitation after trauma remains unclear. We investigated the association between transfusion volume and survival outcome following trauma.
METHODS: Using the Japan Trauma Data Bank (2019-2021), we identified patients 18 years or older who received balanced blood transfusion within the first 24 hours of injury. We evaluated the association between the total number of red blood cell (RBC) units transfused and survival at discharge using logistic regression analysis and generalized additive model. Subgroup analyses based on patient characteristics were performed.
RESULTS: Overall, 5,123 patients from 165 hospitals were eligible for analysis. The transfusion volume was significantly associated with survival rate. Compared with that of patients receiving 4 to 9 RBC units, the within-hospital odds ratios (95% confidence interval) for survival at discharge were 0.62 (0.55-0.75), 0.32 (0.25-0.40), and 0.15 (0.12-0.20) for those receiving 10 to 19, 20 to 29, and ≥30 U, respectively. The probability of survival decreased consistently without any discernible threshold; however, the survival rates remained >40% and >20% even in patients receiving 50 and 80 RBC units, respectively. Significant interactions were observed between the number of RBC units transfused and each subgroup for survival at discharge.
CONCLUSION: The probability of survival consistently diminished as the transfusion volume increased. The absence of a threshold and lack of exceedingly low probability of survival support massive transfusion when clinicians perceive ongoing transfusion as beneficial. The unique context of each clinical situation must be considered in decision making.
LEVEL OF EVIDENCE: Therapeutic/Care Management; Level III.
参考来源
- Shibahashi K, Aoki M, Hikone M, et al. Association between transfusion volume and survival outcome following trauma: Insight into the limit of transfusion from an analysis of nationwide trauma registry in Japan. J Trauma Acute Care Surg. 2023. PMID: 37962149. doi:10.1097/TA.0000000000004206
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。